List of SBIR/STTR awards granted to ReveraGen BioPharma
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to ReveraGen BioPharma in June, 2018 for $178,041.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AR073541-01 | Phase I | 178,041 | June 1, 2018 | |||||||
A SBIR Phase II contract was awarded to ReveraGen BioPharma in September, 2018 for $3,109,059.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44NS095423-03 | Phase II | 3,109,059 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to ReveraGen BioPharma in September, 2020 for $1,680,179.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2SB1NS095423-05A1 | Phase II | 1,680,179 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to ReveraGen BioPharma in June, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AR073547-01 | Phase I | 225,000 | June 5, 2018 | |||||||
A STTR Phase I contract was awarded to ReveraGen BioPharma in July, 2018 for $224,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41HD094622-01 | Phase I | 224,998 | July 1, 2018 |
